RIGL
NASDAQ HealthcareRigel Pharmaceuticals, Inc. - Common Stock
Biotechnology
📊 Market Data
| Price | $26.60 |
|---|---|
| Volume | 417,692 |
| Market Cap | 491.39M |
| Beta | 1.170 |
| RSI (14-Day) | 14.6 Oversold |
| 200-Day MA | $32.58 |
| 50-Day MA | $35.91 |
| 52-Week High | $52.24 |
| 52-Week Low | $15.50 |
| P/E Ratio | 1.37 |
| Forward P/E | 5.55 |
| Price / Book | 1.24 |
🎯 Investment Strategy Scores
How RIGL scores across each investment strategy. Higher is better for that strategy's goals.
💰 Dividend Daddy
21/100
High dividend yield + low volatility
🚀 Moon Shot
83/100
High growth potential (high beta + oversold)
🔪 Falling Knife
91/100
Contrarian plays (oversold + below moving average)
🎈 Over-Hyped
6/100
Overbought stocks (potential short candidates)
🐋 Institutional Whale
13/100
Large-cap, institutional-quality stocks
Find RIGL in your text
Paste any text on the homepage — the tool will extract RIGL and other hidden tickers.
Disclaimer: This data is for educational and entertainment purposes only and does not constitute financial advice. Market data may be delayed. Always do your own research before making investment decisions.